PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
GymBuddy is an online platform that enables consumers to find, book, and attend a gym location, services, or products offered and operated by fitness studios, gyms, trainers, venues, or other third parties. Users can easily, through filtered searches on the app, view descriptions, and contact information of specialists within the fitness industry such as personal trainers, nutritionists, and physiotherapists. The UK fitness industry alone is currently worth over £5 billion. Based on recent statistics, the average gym membership in the UK costs members £40 a month, which often ties them into lengthy contracts. The GymBuddy app will enter the Health & Fitness club sector as a multi-gym membership feature that gives users access to gyms and various fitness plans, without the need for bricks-and-mortar locations under its brand. The company is seeking an investment of £400,000 to expand its brand identity and bring more users to its ecosystem to generate profits.
days to go:
Expired
investment:
Withheld
Farmstand is a plant-powered cloud caterer that is trying to reinvent the way people eat in canteens and outdoor markets. The company asserts that its products are 100% customisable and without any carbon footprint. The menu comprises of 80% vegetables, 65% vegan sources, 5% sustainable fish, and 15% meat. Customers can pre-order, pay, and pick-up via the Farmstand app. Farmstand aims to disrupt the $200 billion catering market which will be doubling by 2032. The company has received a £1.2 million seed investment from London-based VC, Kindred Capital. Till date, the company has served 5.6 million dishes, saved 2.8 million tonnes of plastic, and negated 200 tonnes of landfill waste through its products. The company will use the investment to expand to 1000+ canteens and outdoor markets in 10 cities in 10 years, focus on expanding across the UK, launch a more intuitive app, and expand its team.
days to go:
Expired
investment:
£999,970
Lucy's dressings aim to become the UK's leading dressings and sauces brand. They offer a wide range of award winning product ranges including gluten-free, low fat, vegetarian and low sugar options at affordable prices. As well as their retails range they also offer dressings for 3 restaurant groups, including Bill's and Gourmet Burger Kitchen.
days to go:
Expired
investment:
£218,340
A food chain which cook a blend of the best of Asian cuisines fresh to order: Wok&Go have 24 stores across the UK with plans to open another 13 in the next year. On track to sell over 1.1 million boxes of noodles this year, they are now raising to open a flagship store in London
days to go:
Expired
investment:
£39,940
The Cauldron is a technology-led entertainment studio that aims to deliver immersive experiences to its guests by combining technology with food and drink. Upon entering the company's venues, guests are given a magic wand, which acts as a control device for their visit. It helps them pour pints, activate lights and locks, explore science experiments, and stir cocktails. The device is also programmed to act as an open bar tab to track user spending. The Cauldron has served 1 million potions till date and welcomed 260,000+ guests. It has also inked ticket and product selling partnerships with entities like TimeOut, Airbnb Experiences, Secret London, Virgin Experience Days, and others. The company has featured on publications like Thrillist, NBC, Forbes, and Edinburgh News. The Cauldron will use 70% of the investment to open a central-London Cauldron flagship and provide additions to Wands & Wizard Exploratorium, 20% to finish the build for three new pop-up venues to open in markets across the US and Europe, and 10% to pay staff salaries.
days to go:
Expired
investment:
£304,690
Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.
days to go:
Expired
investment:
£2,160,000
